# Expanded Access to Velmanase Alfa

> **NCT04959240** · — · AVAILABLE · sponsor: **Chiesi Farmaceutici S.p.A.**

## Conditions studied

- Alpha-Mannosidosis

## Interventions

- **DRUG:** Velmanase Alfa

## Key facts

- **NCT ID:** NCT04959240
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04959240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04959240, "Expanded Access to Velmanase Alfa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04959240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*